Imunizante MVA-BN deve ser administrado em duas doses num intervalo de quatro semanas; uma dose do produto mostrou eficácia de 76%; vacina protegeu 82% de pessoas contra a doença ao ser aplicada duas vezes.
Source of original article: United Nations / Nações Unidas (news.un.org). Photo credit: UN. The content of this article does not necessarily reflect the views or opinion of Global Diaspora News (www.globaldiasporanews.net).
To submit your press release: (https://www.globaldiasporanews.com/pr).
To advertise on Global Diaspora News: (www.globaldiasporanews.com/ads).
Sign up to Global Diaspora News newsletter (https://www.globaldiasporanews.com/newsletter/) to start receiving updates and opportunities directly in your email inbox for free.
